001     884904
005     20210130010005.0
024 7 _ |a 2128/25815
|2 Handle
037 _ _ |a FZJ-2020-03308
041 _ _ |a English
100 1 _ |a Chen, Ji
|0 P:(DE-Juel1)171414
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Modeling the psychopathology in schizophrenia: symptom dimensions, subtypes, brain connectivity patterns, and molecular architecture
|f - 2020-10-08
260 _ _ |c 2020
300 _ _ |a 147
336 7 _ |a Output Types/Dissertation
|2 DataCite
336 7 _ |a DISSERTATION
|2 ORCID
336 7 _ |a PHDTHESIS
|2 BibTeX
336 7 _ |a Thesis
|0 2
|2 EndNote
336 7 _ |a Dissertation / PhD Thesis
|b phd
|m phd
|0 PUB:(DE-HGF)11
|s 1601643893_15070
|2 PUB:(DE-HGF)
336 7 _ |a doctoralThesis
|2 DRIVER
502 _ _ |a Dissertation, Heinrich-Heine Universität, 2020
|c Heinrich-Heine Universität
|b Dissertation
|d 2020
520 _ _ |a Summary Schizophrenia is a severe, debilitating, and heterogeneous mental disorder. Disentangling the psychopathological heterogeneity in schizophrenia from its underlying dimensions and the related neurobiology remains a challenge. Although ample efforts have been devoted to their study, symptom dimensions and subtypes, as well as neurobiological substrates and differentiations in schizophrenia remain unclear. In my project, I implemented machine-learning frameworks aiming to develop a new method to robustly and reliably conceptualize the psychopathology of schizophrenia at both symptom and brain levels in a data-driven fashion. First, an orthonormal and projective variant of non-negative matrix factorization (OPNMF) was employed to identify the latent dimensions of the well-established Positive and Negative Syndrome Scale (PANSS). This method is capable of learning compact and homogeneous factors which can be readily generalized to novel patients. By evaluating OPNMF-derived factor models within a large, homogeneous schizophrenia dataset and then cross-validating the yielded models with an independent multi-site sample recruited from Europe, Asia, and the United States, a structure with four dimensions representing negative, positive, affective and cognitive symptoms was identified as the most stable and generalizable. This four-dimensional structure showed higher internal consistency than the original PANSS subscales and previously proposed factor models. Based on the identified dimensions, fuzzy-clustering was employed to derive symptomatically well-separated schizophrenia subtypes. Two core subtypes of schizophrenia patients were identified, with one featuring prominent negative and affective symptoms while the other featuring positive symptomatology. This positive-negative dichotomy was longitudinally stable in about 80% of the repeatedly assessed patients. Neurobiological divergence of the identified subtypes was assessed using classification analysis of resting-state functional MRI measurement with cross-validation in a subset of the multi-site sample. Individual subtypes could be well-discriminated using resting-state functional connectivity (rsFC) profiles of the ventromedial frontal cortex, temporoparietal junction, and precuneus, with the highest classification accuracy of 70%. Individual expression of the four symptom dimensions were predicted using relevance vector machine based on rsFC within 17 meta-analytically defined task-activation networks. A strict validation procedure including 10-fold cross-validation, leave-one-site-out experiments, and generalization to independent samples was conducted to derive robust symptom-network associations. Finally, the significant and robust symptom-predictive networks were spatially correlated with whole-brain density maps of nine receptors and transporters from prior molecular imaging in healthy populations to reveal the molecular architecture related to these networks. The theory-of-mind and the extended socio-affective default networks, which are implicated in social cognition and affective processes, were identified as significantly and robustly predictive of the cognitive symptom dimension. Moreover, node importance of these two networks showed a spatial pattern positively co-varying with D1 dopamine receptor and serotonin reuptake transporter densities as well as presynaptic dopamine capacity.The current work provides a systematic modeling framework of schizophrenia from symptomatology to neurobiology. Together the proposed hybrid dimensional-categorical conceptualization of symptomatology and the revealed intrinsic neurobiological processes and molecular architecture further disentangle the heterogeneity in schizophrenia, possibly allowing for the development of more specifically targeted treatments.
536 _ _ |a 574 - Theory, modelling and simulation (POF3-574)
|0 G:(DE-HGF)POF3-574
|c POF3-574
|f POF III
|x 0
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/884904/files/Chen%20Dissertation%202020.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/884904/files/Chen%20Dissertation%202020.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:884904
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)171414
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-574
|2 G:(DE-HGF)POF3-500
|v Theory, modelling and simulation
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
980 _ _ |a phd
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21